(Reuters) - St. Jude's Current implantable cardioverter defibrillator, or ICD, and Promote cardiac resynchronization therapy defibrillator, known as CRT-D, are the company's first devices to be built on its new consolidated hardware and software platform to support implantable cardiac devices.
The new platform enables the company to more quickly update all devices with new features and diagnostics as they because available because the basic framework for all the devices will be the same.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment